These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35311151)

  • 1. Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming.
    Zuo S; Wang H; Li L; Pan H; Lu L
    Front Oncol; 2022; 12():802807. PubMed ID: 35311151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
    Sun X; Zhang J; Hu J; Han Q; Ge Z
    BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lu JJ; Chen FJ; Li Y; Xu X; Peng C; Yu N; Su LN; Tang L
    Ann Transl Med; 2022 Jan; 10(2):68. PubMed ID: 35282044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
    He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
    Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma.
    Yang Y; Qi F; Wei C; Liu J; Zhang Y; Luan W; Gu J
    Cell Death Discov; 2021 Oct; 7(1):323. PubMed ID: 34716318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma.
    Zhao S; Wen S; Liu H; Zhou Z; Liu Y; Zhong J; Xie J
    Front Surg; 2022; 9():917776. PubMed ID: 36034394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
    Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
    Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GBP2 Is a Favorable Prognostic Marker of Skin Cutaneous Melanoma and Affects Its Progression via the Wnt/β-catenin Pathway.
    Ji G; Luo B; Chen L; Shen G; Tian T
    Ann Clin Lab Sci; 2021 Nov; 51(6):772-782. PubMed ID: 34921030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGAP2-AS1/BRD7/c-Myc signaling axis promotes skin cutaneous melanoma progression.
    Wu L; Li S; Xu J; Shen C; Qian Q
    Am J Transl Res; 2023; 15(1):350-362. PubMed ID: 36777828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
    Jiang Y; Zhang C; Zhang J; Han D; Shi X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
    Weagel EG; Burrup W; Kovtun R; Velazquez EJ; Felsted AM; Townsend MH; Ence ZE; Suh E; Piccolo SR; Weber KS; Robison RA; O'Neill KL
    Cancer Cell Int; 2018; 18():135. PubMed ID: 30214377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition in Thyroid Carcinoma Cells.
    Liu C; Wang J; Zhao L; He H; Zhao P; Peng Z; Liu F; Chen J; Wu W; Wang G; Dong F
    Front Oncol; 2019; 9():1475. PubMed ID: 32064235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating
    Wei X; Gu X; Ma M; Lou C
    Onco Targets Ther; 2019; 12():6323-6335. PubMed ID: 31496735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
    Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
    Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an oxidative stress-associated prognostic risk model for melanoma.
    Yang Y; Long X; Li K; Li G; Yu X; Wen P; Luo J; Tian X; Zhao J
    PeerJ; 2021; 9():e11258. PubMed ID: 33976978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.